Skip to main content
Research and innovation

Antimicrobial drug resistance (AMR)

Research and innovation in antimicrobial resistance (AMR)

AMR occurs when microbes such as fungi, viruses, parasites and bacteria develop resistance to one or more antimicrobial drugs.

In the EU, 33,000 people die each year due to infections caused by resistant bacteria. The burden on the European population is comparable to that of influenza, tuberculosis and HIV/AIDS combined.

Research activities, funded through the research and innovation framework programmes, follow a One Health approach and aim to effectively treat infections in humans and animals by developing new tools and solutions.

The Commission's action plan on AMR focuses on establishing, implementing and monitoring national action plans with EU countries. 

EU Action on Antimicrobial Resistance

Funding opportunities

Horizon Europe

Funding for health under the research and innovation framework programme, Horizon Europe. 

Innovfin Infectious Diseases

Loans supporting research and development in this area

Projects and results

EU-funded projects (CORDIS)

Projects in the field of antimicrobial drug resistance on the Commission's primary portal for results of EU-funded research projects.

Project success stories

Stories of particularly successful EU-funded research projects.

Horizon Results Platform

Platform where framework programme funding recipients present their results to search, contact their owners and form partnerships.

Health programmes database

Database that provides information on the nature of health projects and their results. Managed by the Commission's Consumers, Health, Agriculture and Food Executive Agency.

Collaboration and jobs

Find project partners

Look for project partners and view profiles of all organisations that have received funding via the funding and tender opportunities portal.

Joint Programming Initiative on AMR

17 European countries, Canada and Israel are involved in this initiative aligning research efforts and funding transnational research projects.

New drugs for bad bugs (ND4BB)

Partnership between the Commission and the European pharmaceutical industry. In ND4BB academic and other public partners, small and large pharmaceutical companies team up to advance the development of new antibiotics.

Transatlantic Taskforce on Antimicrobial Resistance (TATFAR)

EU institutions cooperate closely with the governments and specialised agencies of the USA, Canada and Norway in TATFAR with the goal of improving cooperation.

Global AMR R+D hub

The Commission is a leading member of th G20 initiative that aims to further improve the coordination of international efforts and initiatives to tackle AMR


Researcher jobs in related fields

Scientific publications, tools and databases

Horizon 2020 dashboard

Interactive reporting platform, composed of a set of sheets that allows series of views to discover and filter Horizon 2020 data.

Scientific publications

Scientific publications produced by the European Commission (JRC)

EU Open Data Portal

Single point of access to open data produced by the EU institutions. All data free to use for commercial and non-commercial purposes.


You can access all scientific publications from Horizon 2020 via OpenAIRE.